Kusajili – Clinical trials directory

Result of your search per sponsor: Janssen-Cilag, Johnson & Johnson spol. s.r.o

Woman and Man Max 99 years
Janssen-Cilag, Johnson & Johnson spol. s.r.o Update Il y a 4 ans

A Randomized, 6-Week Double-Blind, Placebo-Controlled Study With an Optional 24-Week Open-Label Extension to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With Schizophrenia The primary objective of the study is to evaluate the safety and tolerability of flexible doses of Extended Release (ER) OROS® paliperidone (3 to 12 mg/day) as compared with placebo in subjects with s...

Country None
organs None
Specialty None

Closed trial

More information